Analysis of expression of microRNAs and genes involved in the control of key signaling mechanisms that support or inhibit development of brain tumors of different grades
Abstract
Background MicroRNAs (miRNAs) are a class of small non-coding RNA molecules involved in the regulation of key biological processes. Different miRNAs with pro-oncogenic and anti-oncogenic properties have been identified in glioblastomas. We decided to analyze expression profiles of 10 mature miRNAs (miR-7-1, miR-10а, miR-17, miR-20а, miR-21, miR-23а, miR-26а, miR-137, and miR-222) in post-surgery glioma specimens of different grades in order to find whether the expression level correlates with tumor grades. We also measured expression of six key genes such as PTEN, p21/CDKN1A, MDR1, ABCG2, BAX, and BCL-2 involved in the regulation of critical glioma signaling pathways to establish the effect of miRNAs on these signaling mechanisms. Methods Using RT-PCR, we performed expression analysis of 25 tumor fresh samples (grades II-IV). Results We found gradual increase in miR-21 and miR-23a levels in all tumor grades whereas miR-7 and miR-137 were significantly down-regulated depending on the glioma grade. MDR, ABCG2, and p21/CDKN1A levels were significantly up-regulated while expression of PTEN was down-regulated in tumor samples compared to the normal brain tissue. Conclusions These observations provide new insights into molecular pathogenic mechanisms of glioma progression and suggest about a potential value of miRNAs as a putative diagnostic marker of brain tumors.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Expression changes of miR-23a are related to angiogenesis of glioblastoma microvascular proliferation tissue.
“the expression changes of miR-23a are related to the angiogenesis of glioblastoma microvascular proliferation tissue.”
From Recent advances of miR-23 in human diseases and growth development (2025) · cites this paper as [98]
miR-23a expression level is elevated in postoperative glioma specimens of various grades, and this elevation is associated with downregulation of PTEN expression.
“the expression level of miR-23a is elevated in postoperative glioma specimens of various grades, and this elevation is associated with the downregulation of PTEN expression”
From Recent advances of miR-23 in human diseases and growth development (2025) · cites this paper as [98]
In glioblastoma microvascular proliferation tissue, miR-23 is downregulated, while its target genes ATP5A1 and ATP5B are highly expressed in endothelial cells.
“In this context, miR-23 is downregulated, while its target genes ATP5A1 and ATP5B are highly expressed in endothelial cells.”
From Recent advances of miR-23 in human diseases and growth development (2025) · cites this paper as [98]
Cites
Targeting miR-21 in glioma: a small RNA with big potential
Moore, L. M., & Zhang, W. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2010.527334 · Cited by 51 · see citing works
Palani, M., Devan, S., Arunkumar, R., & Vanisree, A. J. (2011) · Medical Oncology · doi:10.1007/s12032-010-9671-4 · Cited by 10 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Adlakha, Y. K., & Saini, N. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-33 · Cited by 213 · see citing works
Recent advances of miR-23 in human diseases and growth development
Qian, X., Jiang, Y., Yang, Y., Zhang, Y., Xu, N., Xu, B., Pei, K., Yu, Z., & Wu, W. (2025) · Non-coding RNA Research · doi:10.1016/j.ncrna.2024.12.010 · Cited by 5 · see citing works
- Authors
- Koshkin, P. A., Chistiakov, D. A., Nikitin, A. G., Konovalov, A. N., Potapov, A. A., Usachev, D. Y., Pitskhelauri, D. I., Kobyakov, G. L., Shishkina, L. V., & Chekhonin, V. P.
- Affiliations
- Pirogov Russian National Research Medical University (RU)
- Burdenko Neurosurgery Institute (RU)
- Corresponding author
- Koshkin, Philip Alexandrovich
- Chistiakov, Dimitry Alexandrovich
- ORCID
- Venue
- Clinica Chimica Acta
- Publisher
- Elsevier BV
- Published
- 2014-03
- Volume
- 430
- Pages
- 55-62
- ISSN
- 0009-8981 (ISSN-L)
- OpenAlex
- W2027497735
- Cited by
- 32
- References
- 2
- Citations by year
- 2024: 3 · 2023: 1 · 2022: 2 · 2021: 2 · 2020: 7 · 2018: 5 · 2017: 3 · 2016: 2 · 2015: 3 · 2014: 4
- FWCI
- 1.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinica Chimica Acta (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Health Sciences › Medicine › Genetics › Glioma Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
- Keywords
- microRNA, glioma, glioblastoma, tumor grade, miR-21, miR-23a, miR-7, miR-137, PTEN, CDKN1A/p21, MDR1, ABCG2, Bax, Bcl-2, tumor progression, diagnostic biomarkers
- MeSH terms
- Adult, Aged, Brain Neoplasms, Female, Humans, Male, Middle Aged, Signal Transduction, Gene Expression Regulation, Neoplastic, Gene Expression Profiling, MicroRNAs, Young Adult, Neoplasm Grading
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review